The Patent Finder

Terms ending in 2031

Lonza Ltd.

Every in-force patent on Lonza Ltd.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,614,343Process for the Production of a Fatty Acid/Carnitine Derivative
In force
 · High confidence
Capsugel Switzerland AGIn forceHigh confidence
US 8,784,844Arabinogalactan for Enhancing the Adaptive Immune Response
In force
 · High confidence
Capsugel Switzerland AGIn forceHigh confidence
US 8,431,741Process for the Hydrogenation of Ketoesters
In force
 · High confidence
Capsugel Switzerland AGIn forceHigh confidence
US 8,962,277Production Cell Line
In force
 · High confidence
Lonza Ltd.In forceHigh confidence
US 8,470,382Carnitine Granulate and Methods for Its Production
In force
 · High confidence
Capsugel Switzerland AGIn forceHigh confidence
US 9,340,487Halogenated Diethyltoluenediamines
In force
 · High confidence
Arxada Switzerland AGIn forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Lonza Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited